Overview
Jieun Lee practices in Cheonan, Republic of Korea. Ms. Lee is rated as an Experienced expert by MediFind in the treatment of Selective Mutism. Her top areas of expertise are Congenital Hyperinsulinism, Turner Syndrome, Precocious Puberty, Intersex, and Vertebroplasty.
Her clinical research consists of co-authoring 60 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Selective Mutism.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Congenital HyperinsulinismMs. Lee isAdvanced. Learn about Congenital Hyperinsulinism.
- IntersexMs. Lee isAdvanced. Learn about Intersex.
- Kallmann SyndromeMs. Lee isAdvanced. Learn about Kallmann Syndrome.
- Metabolic SyndromeMs. Lee isAdvanced. Learn about Metabolic Syndrome.
- Precocious PubertyMs. Lee isAdvanced. Learn about Precocious Puberty.
- Turner SyndromeMs. Lee isAdvanced. Learn about Turner Syndrome.
- Experienced
- AnosmiaMs. Lee isExperienced. Learn about Anosmia.
- Congenital Adrenal Hyperplasia (CAH)
- Conversion DisorderMs. Lee isExperienced. Learn about Conversion Disorder.
- CraniopharyngiomaMs. Lee isExperienced. Learn about Craniopharyngioma.
- Diabetic KetoacidosisMs. Lee isExperienced. Learn about Diabetic Ketoacidosis.
- Hairy Cell Leukemia (HCL)Ms. Lee isExperienced. Learn about Hairy Cell Leukemia (HCL).